<?xml version="1.0" encoding="UTF-8"?>
<p>About half of the asymptomatic high-risk individuals undergoing screening by LDCT present with more than 1 nodule. At baseline, in the NELSON trial, where the management was based on the largest or most suspicious nodule, malignancy was detected mostly in the largest nodule (97%).
 <sup>[
  <xref rid="R31" ref-type="bibr">31</xref>]
 </sup> However, in the PanCan study, one-fifth of the positive individuals were diagnosed with cancer in a lesion that was not the largest.
 <sup>[
  <xref rid="R27" ref-type="bibr">27</xref>]
 </sup>
</p>
